| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kalra Balkrishan | President and CEO, Director | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra | 19 Dec 2025 | 0001768217 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Award | $0 | +125K | +42.38% | $0.00 | 420K | 17 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of December 17, 2026, December 17, 2027 and December 17, 2028, subject to the reporting person's continued service through each vesting date. |